NMDA-enhancing Agent for the Treatment of Mild Cognitive Impairment

NCT02239003 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Mild Cognitive Impairment

Interventions

DRUG: DAOIB
DRUG: Placebo

Sponsor

Chang Gung Memorial Hospital